{"schema_version":"secwatch.filing_event.v1","accession":"0001193125-23-014676","form_type":"8-K","ticker":"ELV","cik":"0001156039","company_name":"Elevance Health, Inc.","filed_at":"2023-01-25T23:59:59+00:00","discovered_at":"2026-05-14T18:03:43.984827+00:00","generated_at":"2026-06-20T09:11:13.528170+00:00","sec_items":["2.02","9.01"],"event_type":"earnings","sentiment":"positive","materiality_score":0.75,"calibrated_materiality_score":0.75,"confidence":"high","headline":"Elevance Health Q4 GAAP EPS $3.93, adj. $5.23; revenue up 10.1% to $39.7B; FY revenue $155.7B; dividend raised 16%","bullets":["GAAP EPS Q4 $3.93, FY $24.81; adjusted EPS Q4 $5.23, FY $29.07.","Full-year operating revenue $155.7B (+13.7% YoY); operating gain $8.5B (+12.9%).","Medical membership 47.5M (+2.2M YoY); growth in Medicaid, commercial fee-based.","Quarterly dividend raised 16% to $1.48; new annualized rate $5.92 per share.","Board authorized $5.0B increase to share repurchase program; 2023 guidance: GAAP EPS >$29.80, adjusted >$32.60."],"urls":{"canonical":"https://secwatch.observer/filing/0001193125-23-014676","json":"https://secwatch.observer/filing/0001193125-23-014676.json","markdown":"https://secwatch.observer/filing/0001193125-23-014676.md","text":"https://secwatch.observer/filing/0001193125-23-014676.txt","edgar_index":"https://www.sec.gov/Archives/edgar/data/1156039/000119312523014676/0001193125-23-014676-index.htm","edgar_primary_document":"https://www.sec.gov/Archives/edgar/data/1156039/000119312523014676/d418386d8k.htm"},"model":{"generated_by":"deepseek-v4-flash:cloud@v2","generated_at":"2026-06-20T09:11:13.528170+00:00"},"review":{"review_status":"machine_generated","human_reviewed":false,"corrected":false,"correction_note":null,"correction_timestamp":null,"superseded_by":null,"related_filings":[]},"source_grounded_claims":[{"claim_id":"65e5b6692b11f5b694571f1e706facd88c72c1fb","claim":"Elevance Health, Inc. reported year ending December 31, 2023 results: EPS greater than $29.80 per share. Guidance initiated.","evidence_excerpt":"The Company expects GAAP net income to be greater than $29.80 per share in 2023, and adjusted net income to be greater than $32.60 per share.","evidence_source":"SEC 8-K Item 2.02","evidence_url":"https://www.sec.gov/Archives/edgar/data/1156039/000119312523014676/0001193125-23-014676-index.htm","confidence":0.95,"family_label":"Earnings Releases","details":[{"label":"Period","value":"year ending December 31, 2023"},{"label":"EPS","value":"greater than $29.80 per share"},{"label":"Guidance","value":"initiated"},{"label":"Result","value":"guidance update"}],"fact_type":"earnings_release"},{"claim_id":"a3b2e39ddb3f77a336fc8b8020f240346b364cc3","claim":"Elevance Health, Inc. reported year ended December 31, 2022 results: revenue $156 billion, EPS $24.81 per share.","evidence_excerpt":"• Fourth quarter and full year GAAP net income was $3.93 and $24.81 per share • Fourth quarter and full year adjusted net income was $5.23* and $29.07* per share • Full year operating revenue grew 13.7% year-over-year to $156 billion • Full year operating gain grew 12.9% year-over-year to $8.5 billion • Medical enrollment increased 2.2 million members year-over-year to 47.5 million members • Quarterly dividend increased by 16% to $1.48 per share","evidence_source":"SEC 8-K Item 2.02","evidence_url":"https://www.sec.gov/Archives/edgar/data/1156039/000119312523014676/0001193125-23-014676-index.htm","confidence":0.95,"family_label":"Earnings Releases","details":[{"label":"Period","value":"year ended December 31, 2022"},{"label":"Revenue","value":"$156 billion"},{"label":"EPS","value":"$24.81 per share"},{"label":"Result","value":"reported results"}],"fact_type":"earnings_release"},{"claim_id":"aedfbb9031e11157672a2f9064dbec3f30b1c6a6","claim":"Elevance Health, Inc. reported quarter ended December 31, 2022 results: EPS $3.93 per share.","evidence_excerpt":"GAAP net income was $3.93 per share in the fourth quarter, including net negative adjustment items of $1.30 per share.","evidence_source":"SEC 8-K Item 2.02","evidence_url":"https://www.sec.gov/Archives/edgar/data/1156039/000119312523014676/0001193125-23-014676-index.htm","confidence":0.95,"family_label":"Earnings Releases","details":[{"label":"Period","value":"quarter ended December 31, 2022"},{"label":"EPS","value":"$3.93 per share"},{"label":"Result","value":"reported results"}],"fact_type":"earnings_release"}],"license":"Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer"}